振德医疗收盘上涨3.59%，滚动市盈率17.37倍，总市值63.04亿元

Group 1 - The core viewpoint of the news is that Zhend Medical's stock has seen a recent increase, but its price-to-earnings (PE) ratio remains significantly lower than the industry average, indicating potential undervaluation [1] - As of August 12, Zhend Medical's closing price was 23.66 yuan, up 3.59%, with a rolling PE ratio of 17.37, marking a new low in 162 days and a total market capitalization of 6.304 billion yuan [1] - The average PE ratio for the medical device industry is 57.51, with a median of 41.25, positioning Zhend Medical at 36th place within the industry [1] Group 2 - As of March 31, 2025, Zhend Medical had 24,690 shareholders, an increase of 1,808 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares per shareholder [1] - Zhend Medical specializes in the research, production, and sales of medical and health products, including basic care, surgical infection control, pressure treatment, and modern wound care [1] - The latest quarterly report for Q1 2025 shows Zhend Medical achieved a revenue of 999.2 million yuan, a year-on-year increase of 2.87%, while net profit was 51.2419 million yuan, reflecting a year-on-year decrease of 30.19%, with a gross profit margin of 34.28% [1]